Cannex Capital Holdings Inc Stock Canadian Securities Exchange
Equities
CA13768L1085
Pharmaceuticals
Sales 2024 * | 120M 165M | Sales 2025 * | - | Capitalization | 106M 146M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.89 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on Cannex Capital Holdings Inc
Managers | Title | Age | Since |
---|---|---|---|
Founder | 38 | - | |
Andrew Thut
CEO | Chief Executive Officer | 50 | 14-09-30 |
Karl Chowscano
PSD | President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Rob Hunt
CHM | Chairman | 51 | 22-04-11 |
Anthony Dutton
PRN | Corporate Officer/Principal | 66 | - |
Chetan Gulati
BRD | Director/Board Member | 46 | 20-11-30 |
1st Jan change | Capi. | |
---|---|---|
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.18B | |
+3.98% | 3.16B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |